Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication Artículo científico (JournalArticle)

Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years' experience of a reference centre in Spain

  • Castelo, B.
  • Viñal, D.
  • Maseda Fernández, Rubén Horacio
  • Ostios, L.
  • Sánchez Sánchez, David
  • García-Salvatierra, B.
  • Escámez Toledano, María José
  • Martínez Santamaría, Lucía
  • Río Nechaevsky, Marcela del
  • Mora-Rillo, M.
  • Vilches, Y.
  • Beato, M. J.
  • López Gutiérrez, J. C.
  • Romero, N.
  • Santos, C.
  • Miranda, J.
  • De Lucas, R.
Background: Cutaneous squamous cell carcinoma (cSCC) is the leading cause of death in patients with recessive dystrophic epidermolyisis bullosa (RDEB). We provide the management and prognosis of cSCC in RDEB patients at a Spanish reference center. Material and methods: We retrospectively included patients with RDEB attended in La Paz University Hospital (LPUH) from November 1988 to October 2018. Results: Fourteen patients developed at least one cSCC. Tumors were predominantly well differentiated. Nearly half of the tumors have recurred. Median time to first recurrence was 23.4 months (95%CI:17.2- 29.5). Five patients have developed distant metastases. Median overall survival (mOS) was 136.5 months since the diagnosis of the first cSCC (95%CI: 30.6-242.3). When distant metastases occurred, mOS was 6.78 months (95CI%: 1.94-11.61). Conclusions: cSCC is a life-threatening complication of RDEB patients. Although tumors are usually well differentiated, they tend to relapse. This is the first Spanish report of cSCC arising in RDEB patients., The authors from UC3M-CIEMAT-CIBERER-IISFJD group are grateful for funding received from the Community of Madrid (AvanCell-CM: B2017/BMD-3692), from the European Union (GENEGRAFT: HEALTH-F2-2011-261392), from the Carlos III Institute of Health and ERDF, “Investing in your future” (AES_ICI14/00327- ICI14/00363), from ERDF/The Spanish Ministry of Science, Innovation and Universities – Agencia Estatal de Investigación (SAF2017-86810-R), and from the Patient Associations, Berritxuak and DEBRA España.
e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication Artículo científico (JournalArticle)

Assessment of the risk and characterization of non-melanoma skin cancer in Kindler syndrome: study of a series of 91 patients

  • Guerrero Aspizua, Sara
  • Conti, Claudio Jorge
  • Escámez Toledano, María José
  • Castiglia, Daniele
  • Zambruno, Giovanna
  • Youssefian, Leila
  • Vahidenezhad, Hassan
  • Requena, Luis
  • Hin, Peter
  • Tadini, Gianluca
  • Yordanova, Ivelina
  • Martin, Ludovic
  • Uitto, Jouni
  • Has, Cristina
  • Río Nechaevsky, Marcela del
Background: Kindler Syndrome (KS) is a rare genodermatosis characterized by skin fragility, skin atrophy, premature aging and poikiloderma. It is caused by mutations in the FERMT1 gene, which encodes kindlin-1, a protein involved in integrin signalling and the formation of focal adhesions. Several reports have shown the presence of non-melanoma skin cancers in KS patients but a systematic study evaluating the risk of these tumors at different ages and their potential outcome has not yet been published. We have here addressed this condition in a retrospective study of 91 adult KS patients, characterizing frequency, metastatic potential and body distribution of squamous cell carcinoma (SCC) in these patients. SCC developed in 13 of the 91 patients. Results: The youngest case arose in a 29-year-old patient; however, the cumulative risk of SCC increased to 66.7% in patients over 60 years of age. The highly aggressive nature of SCCs in KS was confirmed showing that 53.8% of the patients bearing SCCs develop metastatic disease. Our data also showed there are no specific mutations that correlate directly with the development of SCC; however, the mutational distribution along the gene appears to be different in patients bearing SCC from SCC-free patients. The body distribution of the tumor appearance was also unique and different from other bullous diseases, being concentrated in the hands and around the oral cavity, which are areas of high inflammation in this disease. Conclusions: This study characterizes SCCs in the largest series of KS patients reported so far, showing the high frequency and aggressiveness of these tumors. It also describes their particular body distribution and their relationship with mutations in the FERMT-1 gene. These data reinforce the need for close monitoring of premalignant or malignant lesions in KS patients., Science and Innovation Ministry of Spain (SAF2013-43475); Comunidad de Madrid (S2010/BMD-2420, B2017/BMD-3692); Instituto de Salud Carlos III (PI14/00931); DEBRA International and European Union (HEALTH-F2-2011-261392); CIBER-ER17PE01 and Italian Ministry of Health grant (Ricerca Corrente RC2017-1.2 to D.C).
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses

  • Chacón-Solano, Esteban|||0000-0002-5697-7625
  • León Canseco, Carlos
  • Díaz, F.
  • García-García, Francisco
  • García, Montserrat|||0000-0002-3437-3185
  • Escámez, M.J.|||0000-0002-5434-1885
  • Guerrero-Aspizua, Sara
  • Conti, C.J.
  • Mencía, None
  • Martínez Santamaría, Lucía|||0000-0002-9637-2364
  • Llames, Sara|||0000-0001-5456-1389
  • Pévida, M.
  • Carbonell-Caballero, J.
  • Puig-Butille, Joan Anton
  • Maseda Pedrero, Rocío
  • Puig, Susana|||0000-0003-1337-9745
  • Lucas, Raúl de
  • Baselga Torres, Eulàlia|||0000-0003-1086-8439
  • Larcher, Fernando
  • Dopazo, Joaquín|||0000-0003-3318-120X
  • del Río, Marcela
Background: Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three cancer-prone genodermatoses whose causal genetic mutations cannot fully explain, on their own, the array of associated phenotypic manifestations. Recent evidence highlights the role of the stromal microenvironment in the pathology of these disorders. Objectives: To investigate, by means of comparative gene expression analysis, the role played by dermal fibroblasts in the pathogenesis of RDEB, KS and XPC. Methods: We conducted RNA-Seq analysis, which included a thorough examination of the differentially expressed genes, a functional enrichment analysis and a description of affected signalling circuits. Transcriptomic data were validated at the protein level in cell cultures, serum samples and skin biopsies. Results: Interdisease comparisons against control fibroblasts revealed a unifying signature of 186 differentially expressed genes and four signalling pathways in the three genodermatoses. Remarkably, some of the uncovered expression changes suggest a synthetic fibroblast phenotype characterized by the aberrant expression of extracellular matrix (ECM) proteins. Western blot and immunofluorescence in situ analyses validated the RNA-Seq data. In addition, enzyme-linked immunosorbent assay revealed increased circulating levels of periostin in patients with RDEB. Conclusions: Our results suggest that the different causal genetic defects converge into common changes in gene expression, possibly due to injury-sensitive events. These, in turn, trigger a cascade of reactions involving abnormal ECM deposition and underexpression of antioxidant enzymes. The elucidated expression signature provides new potential biomarkers and common therapeutic targets in RDEB, XPC and KS. What's already known about this topic?. Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three genodermatoses with high predisposition to cancer development. Although their causal genetic mutations mainly affect epithelia, the dermal microenvironment likely contributes to the physiopathology of these disorders. What does this study add?. We disclose a large overlapping transcription profile between XPC, KS and RDEB fibroblasts that points towards an activated phenotype with high matrix-synthetic capacity. This common signature seems to be independent of the primary causal deficiency, but reflects an underlying derangement of the extracellular matrix via transforming growth factor-β signalling activation and oxidative state imbalance. What is the translational message?. This study broadens the current knowledge about the pathology of these diseases and highlights new targets and biomarkers for effective therapeutic intervention. It is suggested that high levels of circulating periostin could represent a potential biomarker in RDEB.